<DOC>
<DOCNO>
EP-0010061
</DOCNO>
<TEXT>
<DATE>
19800416
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/165 A61K-31/405 A61K-31/38 A61K-31/195 A61K-31/60 A61K-45/00 A61K-31/415 A61K-31/135 A61K-35/60 <main>A61K-35/60</main> A61K-31/21 A61K-31/44 A61K-31/215 A61P-25/04 A61K-31/19 A61K-31/403 A61P-25/00 A61K-31/185 A61K-35/56 A61P-29/00 A61K-45/06 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical preparations containing a mollusc extract.
</TITLE>
<APPLICANT>
croft john ericnz<sep>mc farlane stuart johnnz<sep>croft, john eric<sep>mc farlane, stuart john<sep>croft, john eric56 waimarie rdwhenuapai village aucklandnz<sep>mc farlane, stuart john5 montmere ave te atatuaucklandnz<sep>croft, john eric<sep>mc farlane, stuart john<sep>
</APPLICANT>
<INVENTOR>
mc farlane stuart john<sep>mc farlane, stuart john<sep>croft, john eric56 waimarie rdwhenuapai village aucklandnz<sep>mc farlane, stuart john5 montmere ave te atatuaucklandnz<sep>mc farlane, stuart john<sep>croft, john eric56 waimarie rdwhenuapai village aucklandnz<sep>mc farlane, stuart john5 montmere ave te atatuaucklandnz<sep>
</INVENTOR>
<ABSTRACT>
the invention concerns novel pharmaceutical prepara­ tions containing a) an extract of the mollusc perna  canaliculus, a mussel which is found on the shores of new  zealand, and b) a pharmaceutically active substance, espe­ cially medicaments having anti-phlogistic, antipyretic and/or  analgetic action, which, when taken per se, may cause as a  side effect irritation of the gastro-intestinal mucosae and  possibly the formation of ulcers.  the addition of a mollusc  extract according to a) to the said medicaments has a gastro-­ protective action, in that the occurence of the said side effects  is prevented or diminished.  the component a) is preferably  used as a dry powder of the whole of the flesh of the mollusc  or a dry powder obtained from the gonads thereof.  in a typical  preparation according to the invention an extract of the  gonads is e. g.  combined with acetyl-salicylic acid.  the prep­ arations may contain the 2 components in one and the same  dosage unit form, e. g.  a capsule or in 2 different ones, e. g.  a  capsule and a tablet.  the invention also includes a method for preventing,  alleviating or a treating gastro-intestinal irritation or ulcer  formation by administering an effective amount of the mol­ lusc extract as defined under a.  
</ABSTRACT>
</TEXT>
</DOC>
